Gene · 2596
Papers3,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recipient Reaction and Composition of Autologous Sural Nerve Tissue Grafts into the Human Brain. | J Clin Med | 2023 | 37834764 | PubTator, text mining | PubMed |
| Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice. | Int J Mol Sci | 2023 | 37834084 | PubTator, text mining | PubMed |
| Comparative assessment of Alzheimer's disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study. | Front Mol Biosci | 2023 | 37828917 | PubTator, text mining | PubMed |
| Spatiotemporal molecular dynamics of the developing human thalamus. | Science | 2023 | 37824646 | PubTator, text mining | PubMed |
| Alternating current stimulation promotes neurite outgrowth and plasticity in neurons through activation of the PI3K/AKT signaling pathway. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37814815 | PubTator, text mining | PubMed |
| Scratching increases epidermal neuronal branching and alters psychophysical testing responses in atopic dermatitis and brachioradial pruritus. | Front Mol Neurosci | 2023 | 37795274 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecularly distinct subtypes in retinoblastoma. | Sci Rep | 2023 | 37777551 | PubTator, text mining | PubMed |
| Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. | NPJ Regen Med | 2023 | 37773257 | PubTator, text mining | PubMed |
| Cell Cycle Reactivation, at the Start of Neurodegeneration, Induced by Forskolin and Aniline in Differentiated Neuroblastoma Cells. | Int J Mol Sci | 2023 | 37762676 | PubTator, text mining | PubMed |
| Use of Cells, Supplements, and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update. | Int J Mol Sci | 2023 | 37762251 | PubTator, text mining | PubMed |
| New Challenges for Anatomists in the Era of Omics. | Diagnostics (Basel) | 2023 | 37761332 | PubTator, text mining | PubMed |
| Refining S-acylation: Structure, regulation, dynamics, and therapeutic implications. | J Cell Biol | 2023 | 37756661 | PubTator, text mining | PubMed |
| A mechanosensing mechanism controls plasma membrane shape homeostasis at the nanoscale. | Elife | 2023 | 37747150 | PubTator, text mining | PubMed |
| Expression of the schizophrenia associated gene FEZ1 in the early developing fetal human forebrain. | Front Neurosci | 2023 | 37746155 | PubTator, text mining | PubMed |
| Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications. | Front Physiol | 2023 | 37745252 | PubTator, text mining | PubMed |
| Summary of drug therapy to treat cognitive impairment-induced obstructive sleep apnea. | Front Cell Neurosci | 2023 | 37731463 | PubTator, text mining | PubMed |
| What is the most predictive magnetic resonance imaging finding of rotator cuff tear concomitant with shoulder stiffness? | JSES Int | 2023 | 37719831 | PubTator, text mining | PubMed |
| Levels of organophosphate flame retardants and their metabolites among 391 volunteers in Taiwan: difference between adults and children. | Front Public Health | 2023 | 37711251 | PubTator, text mining | PubMed |
| Activation of vascular endothelial cells by synovial fibrosis promotes Netrin-1-induced sensory nerve sprouting and exacerbates pain sensitivity. | J Cell Mol Med | 2023 | 37702437 | PubTator, text mining | PubMed |
| Recent advances in lipid nanovesicles for targeted treatment of spinal cord injury. | Front Bioeng Biotechnol | 2023 | 37691909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2596/papers?page=18